Ireland Overhauls Biopharma Tariffs to Spur RD and Trade

Ireland Overhauls Biopharma Tariffs to Spur RD and Trade

Ireland has released a biopharmaceutical tariff adjustment plan aimed at reducing R&D and compliance costs, and strengthening its global competitiveness. The new policy focuses on tax reductions for R&D equipment, adaptation to new EU regulations, incentives for high-value drug exports, and restrictions on low-value-added product exports. This move aims to address challenges such as the impact of new EU regulations and increased global competition. It is expected to promote the quality and efficiency of Ireland's biopharmaceutical industry, optimize the global trade landscape, and inject new impetus into Sino-Irish and EU-Irish pharmaceutical trade.

Feds Waller Suggests Rate Cut Pause As Job Market Holds Strong

Feds Waller Suggests Rate Cut Pause As Job Market Holds Strong

Federal Reserve Governor Waller highlighted labor market weakness as a primary concern, suggesting that a rebound in the job market could end expectations for interest rate cuts. He focused on increased layoff plans, declining consumption among low- and middle-income families, and the potential for AI investment to squeeze employment. He also noted that the Fed's balance sheet is nearing a warning level, necessitating attention to bank reserve conditions. Waller's remarks foreshadow the Fed's future policy direction, emphasizing the job market's crucial role and the non-inevitability of rate cuts, while underscoring the importance of independence.